- Home
- IDN vs ATRA Comparison
IDN vs ATRA Comparison
Compare IDN & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IDN | ATRA |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.5M | 81.2M |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IDN | ATRA |
|---|---|---|
| Price | $2.82 | $9.00 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 3 | 2 |
| Target Price | ★ $7.33 | $5.00 |
| AVG Volume (30 Days) | ★ 463.7K | 44.7K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | 122.52 |
| EPS | ★ 0.06 | N/A |
| Revenue | $4,433,454.00 | ★ $120,772,000.00 |
| Revenue This Year | $12.54 | N/A |
| Revenue Next Year | $15.32 | N/A |
| P/E Ratio | $47.33 | ★ N/A |
| Revenue Growth | ★ 23.21 | N/A |
| 52 Week Low | $2.70 | $3.92 |
| 52 Week High | $9.08 | $19.15 |
Technical Indicators
Market Signals| Indicator | IDN | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 27.47 | 51.47 |
| Support Level | $2.70 | $9.03 |
| Resistance Level | $4.49 | $11.17 |
| Average True Range (ATR) | 0.16 | 0.66 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 11.40 | 62.01 |
Price Performance
Historical ComparisonAbout IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.